In This Article:
It has been about a month since the last earnings report for Avanos Medical (AVNS). Shares have lost about 5.8% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Avanos Medical due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
How Have Estimates Been Moving Since Then?
It turns out, estimates revision have trended downward during the past month.
The consensus estimate has shifted -35.09% due to these changes.
VGM Scores
At this time, Avanos Medical has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a D. However, the stock was allocated a grade of A on the value side, putting it in the top quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Avanos Medical has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry Player
Avanos Medical is part of the Zacks Medical - Instruments industry. Over the past month, Alcon (ALC), a stock from the same industry, has gained 5.3%. The company reported its results for the quarter ended December 2024 more than a month ago.
Alcon reported revenues of $2.48 billion in the last reported quarter, representing a year-over-year change of +6.2%. EPS of $0.72 for the same period compares with $0.70 a year ago.
For the current quarter, Alcon is expected to post earnings of $0.77 per share, indicating a change of -1.3% from the year-ago quarter. The Zacks Consensus Estimate has changed -7.4% over the last 30 days.
Alcon has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of D.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AVANOS MEDICAL, INC. (AVNS) : Free Stock Analysis Report
Alcon (ALC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).